Indiana University School of Medicine researchers have identified a new genetic marker that could play a role in the development of Alzheimer’s disease, which is characterized by two primary pathologies: amyloid-beta plaques and neurofibrillary tau tangles. Their findings, recently published in Nature Communications, could pave the way for novel therapeutic targets and diagnostic tools for the disease.
This article was originally published on MedicalXpress.com